Insider Transactions in Q2 2021 at Accelerate Diagnostics, Inc (AXDX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2021
|
Jack Phillips Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
23,479
-17.24%
|
$164,353
$7.94 P/Share
|
|
Jun 22
2021
|
Jack Phillips Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
62,160
+31.34%
|
-
|
|
May 13
2021
|
Jack Phillips Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,064
-25.3%
|
$150,384
$6.76 P/Share
|
|
May 13
2021
|
Ron Price Head of Commercial Operations |
SELL
Open market or private sale
|
Direct |
6,282
-29.62%
|
$37,692
$6.76 P/Share
|
|
May 13
2021
|
Steven Reichling Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
8,303
-19.32%
|
$49,818
$6.76 P/Share
|
|
May 12
2021
|
Jack Phillips Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
79,893
+44.64%
|
-
|
|
May 12
2021
|
Ron Price Head of Commercial Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
19,335
+47.69%
|
-
|
|
May 12
2021
|
Steven Reichling Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
27,392
+38.93%
|
-
|
|
Apr 09
2021
|
Thomas D Brown Director |
BUY
Grant, award, or other acquisition
|
Direct |
8,680
+18.65%
|
$60,760
$7.68 P/Share
|
|
Apr 09
2021
|
Mark C Miller Director |
BUY
Grant, award, or other acquisition
|
Indirect |
13,020
+33.33%
|
$91,140
$7.68 P/Share
|
|
Apr 09
2021
|
John Patience Director |
BUY
Grant, award, or other acquisition
|
Indirect |
21,701
+0.5%
|
$151,907
$7.68 P/Share
|
|
Apr 09
2021
|
Jack Phillips Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,340
+18.45%
|
$30,380
$7.68 P/Share
|
|
Apr 09
2021
|
Matthew Strobeck Director |
BUY
Grant, award, or other acquisition
|
Indirect |
19,531
+9.44%
|
$136,717
$7.68 P/Share
|